Pharmaceutical GMP readiness in Australia
Australia's Therapeutic Goods Administration (TGA) regulates medicines under the Therapeutic Goods Act 1989. Australian GMP is the PIC/S Guide to GMP (PE 009, current version) plus annexes, adopted by reference. Domestic manufacturers need a manufacturing licence; overseas manufacturers supplying the Australian Register of Therapeutic Goods (ARTG) need a GMP Clearance (CV — Compliance Verification, MRA, or Desktop). TGA is a long-standing PIC/S member with an EU–AU MRA for human medicines. This guide covers the Australia layer over an ICH Q10 PQS.
Regulator and legal basis
Manufacturing licence and GMP Clearance
Release model and distribution
Inspection style and common findings
A 90–180 day Australia readiness path
Standards covered in this guide
Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.
The international model for a Pharmaceutical Quality System covering the entire product lifecycle from development to discontinuation.
European equivalent of 21 CFR Part 11 — rules for computerised systems in GMP.
The EU GMP chapter that mandates VMP, DQ, IQ, OQ, PQ, PPQ and on-going verification for every regulated EU manufacturer.
EU GMP Annex 1 (revision effective 25 August 2023, with full lyophilisation-section compliance from 25 August 2024) is the world's most influential sterile-manufacturing standard — adopted by EU, MHRA
The nine-letter mnemonic regulators use to grade your data integrity — and what every Part 11 audit really tests.
Where this lives in V5 Ultimate
The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.
Frequently asked
Do we need a TGA inspection if we have an EU GMP certificate?
What is the difference between MRA Clearance and CV Clearance?
Does Australia have a QP?
See it on your shop floor.
Free trial, no credit card, onboard in days, not months.
- Global pharmaceutical GMP readiness — ICH, PIC/S, and country roll-up
- Brazil pharmaceutical GMP readiness — ANVISA, RDC 658/2022, CBPF, SNCM
- Canada pharmaceutical GMP readiness — Health Canada, FDR Div. 2, DEL
- China pharmaceutical GMP readiness — NMPA, Drug Administration Law, 2010 GMP
- EU pharmaceutical GMP readiness — EudraLex Vol 4, QP release, EU GDP
- GCC pharmaceutical GMP readiness — Saudi SFDA, GCC-DR, UAE MOHAP, RSD
- Global pharmaceutical GMP readiness — ICH, PIC/S, and country roll-up
- India pharmaceutical GMP readiness — CDSCO, Schedule M, Drugs and Cosmetics Act
